Medical Engineering & Physics
Volume 29, Issue 1 , Pages 72-75 , January 2007

Is the “instant flow” option on the NIOX® analyser needed?

Received 12 November 2005 ,Revised 25 January 2006 ,Accepted 1 February 2006.

References 

  1. Nelson BV, Sears S, Woods J, Ling CY, Hunt J, Clapper LM, et al. Expired nitric oxide as a marker for childhood asthma. J Pediatr. 1997;130:423–427
  2. Pijnenburg MW, Hofhuis W, Hop WC, de Jongste JC. Exhaled nitric oxide predicts asthma relapse in children with clinical asthma remission. Thorax. 2005;60:215–218
  3. Malmberg LP, Pelkonen AS, Haahtela T, Turpeinen M. Exhaled nitric oxide rather than lung function distinguishes preschool children with probable asthma. Thorax. 2003;58(6):494–499
  4. Smith AD, Cowan JO, Brassett KP, Filsell S, McLachlan C, Monti-Sheehan G, et al. Exhaled nitric oxide: a predictor of steroid response. Am J Respir Crit Care Med. 2005;172:453–459
  5. Landau LI. Asthma: prognosis. In: Taussig , Landau  editor. Pediatric respiratory medicine. St. Louis: Mosby; 1998;p. 935–937
  6. Napier E, Turner SW. Methodological issues related to exhaled nitric oxide measurement in children aged four to six years. Pediatr Pulmonol. 2005;37:24–30
  7. Silkoff PE, McClean PA, Slutsky AS, Furlott HG, Hoffstein E, Wakita S, et al. Marked flow-dependence of exhaled nitric oxide using a new technique to exclude nasal nitric oxide. Am J Respir Crit Care Med. 1997;155:260–267
  8. ATS/ERS recommendations for standardized procedures for the online and offline measurement of exhaled lower respiratory nitric oxide and nasal nitric oxide. Am J Respir Crit Care Med 2005;171:912–30.
  9. Mondino C, Koch P, Pistelli R, Trove A, Barnes PJ, Montuschi P. Effects of inhaled corticosteroids on exhaled leukotrienes and prostanoids in asthmatic children. J Allergy Clin Immunol. 2004;114:761–767
  10. Bland JM, Altman DG. Statistical methods for assessing agreement between two methods of clinical measurement. Lancet. 1986;8476:307–310
  11. Silkoff PE, Carlson M, Bourke T, Katial R, Ogren E, Szefler SJ. The Aerocrine exhaled nitric oxide monitoring system NIOX is cleared by the US Food and Drug Administration for monitoring therapy in asthma. J Allergy Clin Immunol. 2004;114:1241–1256

PII: S1350-4533(06)00039-7

doi: 10.1016/j.medengphy.2006.02.002

Medical Engineering & Physics
Volume 29, Issue 1 , Pages 72-75 , January 2007

Article Tools

* Image Usage & Resolution